These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9925308)

  • 1. Synthesis and evaluation of 2-amino-6-fluoro-9-(2-hydroxyethoxymethyl)purine esters as potential prodrugs of acyclovir.
    Kim DK; Lee N; Im GJ; Kim HT; Kim KH
    Bioorg Med Chem; 1998 Dec; 6(12):2525-30. PubMed ID: 9925308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 2-amino-6-fluoro-9-(4-hydroxy-3-hydroxymethylbut-1-yl)purine mono- and diesters as potential prodrugs of penciclovir.
    Kim DK; Lee N; Kim HT; Im GJ; Kim KH
    Bioorg Med Chem; 1999 Mar; 7(3):565-70. PubMed ID: 10220040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 2-amino-9-(1, 3-dihydroxy-2-propoxymethyl)- 6-fluoropurine mono- and diesters as potential prodrugs of ganciclovir.
    Kim DK; Chang K; Im GJ; Kim HT; Lee N; Kim KH
    J Med Chem; 1999 Jan; 42(2):324-8. PubMed ID: 9925738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 2-amino-9-(3-hydroxymethyl-4-alkoxycarbonyloxybut-1-yl)purines as potential prodrugs of penciclovir.
    Kim DK; Lee N; Kim YW; Chang K; Kim JS; Im GJ; Choi WS; Jung I; Kim TS; Hwang YY; Min DS; Um KA; Cho YB; Kim KH
    J Med Chem; 1998 Aug; 41(18):3435-41. PubMed ID: 9719596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML; Murray A; de Miranda P
    Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and evaluation of 2-amino-9-(3-acyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1- yl)purines as potential prodrugs of penciclovir.
    Kim DK; Lee N; Ryu DH; Kim YW; Kim JS; Chang K; Im GJ; Choi WS; Cho YB; Kim KH; Colledge D; Locarnini S
    Bioorg Med Chem; 1999 Aug; 7(8):1715-25. PubMed ID: 10482463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses, chemical and enzymatic stability of new poly(ethylene glycol)-acyclovir prodrugs.
    Zacchigna M; Di Luca G; Maurich V; Boccù E
    Farmaco; 2002 Mar; 57(3):207-14. PubMed ID: 11989799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
    Purifoy DJ; Beauchamp LM; de Miranda P; Ertl P; Lacey S; Roberts G; Rahim SG; Darby G; Krenitsky TA; Powell KL
    J Med Virol; 1993; Suppl 1():139-45. PubMed ID: 8245881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
    Beutner KR
    Antiviral Res; 1995 Dec; 28(4):281-90. PubMed ID: 8669888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
    Field HJ; Tewari D; Sutton D; Thackray AM
    Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
    Garré B; Shebany K; Gryspeerdt A; Baert K; van der Meulen K; Nauwynck H; Deprez P; De Backer P; Croubels S
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4308-14. PubMed ID: 17846132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of amino acid esters of 6-deoxypenciclovir as potential prodrugs of penciclovir.
    Kim DK; Lee N; Kim YW; Chang K; Im GJ; Choi WS; Kim KH
    Bioorg Med Chem; 1999 Feb; 7(2):419-24. PubMed ID: 10218837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
    Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
    Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
    Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
    Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
    Eksborg S; Pal N; Kalin M; Palm C; Söderhäll S
    Med Pediatr Oncol; 2002 Apr; 38(4):240-6. PubMed ID: 11920787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.